The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The prevention of type 2 diabetes
Open accessAbstract
Type 2 diabetes mellitus (T2DM) affects more than 7% of adults in the US and leads to substantial personal and economic burden. In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM in high-risk groups, although weight loss has the greatest effect. Various medications (e.g. metformin, thiazolidinediones and acarbose) can also prevent or delay T2DM. Whether diabetes-prevention strategies also ultimately prevent the development of diabetic vascular complications is unknown, but cardiovascular risk factors are favorably affected. Preventive strategies that can be implemented in routine clinical settings have been developed and evaluated. Widespread application has, however, been limited by local financial considerations, even though cost-effectiveness might be achieved at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings that both lifestyle and metformin interventions delayed or prevented diabetes in the DPPOS are consistent with results of other reports of similar interventions with lifestyle or with other antidiabetic drugs.24,25”
From 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) · cites this paper as [24]
In the citing paper
“In the Diabetes Prevention Program (DPP), metformin reduced the development of diabetes by 31% over an average of 2.8 years of follow-up (4,5).”
From Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study (2012) · cites this paper as [5]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [21]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [22]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Self-citationAcarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Self-citationWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
The Cochrane Database of Systematic Reviews
Handoll, H. H. (2004) · The British Journal of Hand Therapy · doi:10.1177/175899830400900201 · Cited by 1,513
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Standards of Medical Care in Diabetes—2008
Dora, J. M., Kramer, C. K., & Canani, L. H. (2008) · Diabetes Care · doi:10.2337/dc08-0109 · Cited by 1,409
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Effect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344
Self-citationBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Orchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
Self-citationFreeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 839
Self-citationEffect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
The Cochrane Database of Systematic Reviews – Issue 4 2008
Clarke, M. (2008) · Journal of Evidence-Based Medicine · doi:10.1111/j.1756-5391.2008.00009.x · Cited by 658
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
Kosaka, K., Noda, M., & Kuzuya, T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.010 · Cited by 656
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Self-citationRubino, F., Gagner, M., Gentileschi, P., Kini, S., Fukuyama, S., Feng, J., & Diamond, E. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133117.12646.48 · Cited by 639
Physical Activity in the Prevention of Type 2 Diabetes
Laaksonen, D. E., Lindström, J., Lakka, T. A., Eriksson, J. G., Niskanen, L., Wikström, K., Aunola, S., Keinänen-Kiukaanniemi, S., Laakso, M., Valle, T. T., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.158 · Cited by 614
The Diabetes Prevention Program Research Group (2005) · Diabetes Care · doi:10.2337/diacare.28.4.888 · Cited by 572
Ramipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541
Sever, P. S., Dahl??f, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2004) · Drugs · doi:10.2165/00003495-200464002-00005 · Cited by 524
Stern, M. P., Williams, K., & Haffner, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00006 · Cited by 510
Self-citationCollins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1321 · Cited by 358
Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Brown, T., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004095.pub2 · Cited by 351
Surgical treatment of obesity and its effect on diabetes: 10-y follow-up
Pories, W., MacDonald, K., Morgan, E., Sinha, M., Dohm, G., Swanson, M., Barakat, H., Khazanie, P., Leggett-Frazier, N., Long, S., et al. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.582s · Cited by 345
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333
Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318
Keech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R. J., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2713 · Cited by 313
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Self-citationSartor, G., Scherstén, B., Carlström, S., Melander, A., Nordén, Å., & Persson, G. (1980) · Diabetes · doi:10.2337/diab.29.1.41 · Cited by 285
The ten-year follow-up of the Bedford Survey (1962?1972): Glucose tolerance and diabetes
Keen, H., Jarrett, R. J., & McCartney, P. (1982) · Diabetologia · doi:10.1007/bf00254832 · Cited by 283
Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity
Hattersley, A. T. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199801)15:1<66::aid-dia515>3.0.co;2-a · Cited by 282
The Diabetes Prevention Program Research Group [Prepared by Jill Crandall, D. S. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1075 · Cited by 254
The DREAM trial – Authors' reply
Gerstein, H. C., Yusuf, S., & Bosch, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69829-2 · Cited by 253
Prevention or Delay of Type 2 Diabetes
American Diabetes Association, & National Institute of Diabetes and Digestive and Kidney Diseases (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s47 · Cited by 240
Dixon, A. F. R., Dixon, J. B., & O’Brien, P. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1546 · Cited by 228
Carnethon, M. R., Prineas, R. J., Temprosa, M., Zhang, Z.-M., Uwaifo, G., Molitch, M. E., & for the Diabetes Prevention Program Research Group (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1729 · Cited by 220
Long, S. D., O'brien, K., Macdonald, K. G., Leggett-Frazier, N., Swanson, M. S., Pories, W. J., & Caro, J. F. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.372 · Cited by 220
Adapting the Diabetes Prevention Program Lifestyle Intervention for Delivery in the Community
Ackermann, R. T., & Marrero, D. G. (2007) · The Diabetes Educator · doi:10.1177/0145721706297743 · Cited by 220
Self-citationThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.977 · Cited by 218
National type 2 diabetes prevention programme in Finland: FIN-D2D
Saaristo, T., Peltonen, M., Keinänen-Kiukaanniemi, S., Vanhala, M., Saltevo, J., Niskanen, L., Oksa, H., Korpi-Hyøvälti, E., & Tuomilehto, J. (2007) · International Journal of Circumpolar Health · doi:10.3402/ijch.v66i2.18239 · Cited by 210
Worsening to diabetes in men with impaired glucose tolerance (?borderline diabetes?)
Jarrett, R. J., Keen, H., Fuller, J. H., & McCartney, M. (1979) · Diabetologia · doi:10.1007/bf00423146 · Cited by 201
Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?
PORIES, W. J., MACDONALD, K. G., FLICKINGER, E. G., DOHM, G. L., SINHA, M. K., BARAKAT, H. A., MAY, H. J., KHAZANIE, P., SWANSON, M. S., MORGAN, E., et al. (1992) · Annals of Surgery · doi:10.1097/00000658-199206000-00010 · Cited by 190
Wang, J., Kuusisto, J., Vänttinen, M., Kuulasmaa, T., Lindström, J., Tuomilehto, J., Uusitupa, M., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0656-6 · Cited by 178
Preventing Non-Insulin-Dependent Diabetes
Knowler, W. C., Narayan, K. M. V., Hanson, R. L., Nelson, R. G., Bennett, P. H., Tuomilehto, J. O., Scherstén, B., & Pettitt, D. J. (1995) · Diabetes · doi:10.2337/diab.44.5.483 · Cited by 178
Self-citationCost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians
Ramachandran, A., Snehalatha, C., Yamuna, A., Mary, S., & Ping, Z. (2007) · Diabetes Care · doi:10.2337/dc07-0150 · Cited by 162
Adherence to Preventive Medications
Walker, E. A., Molitch, M., Kramer, M. K., Kahn, S., Ma, Y., Edelstein, S., Smith, K., Johnson, M. K., Kitabchi, A., Crandall, J., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0454 · Cited by 161
Self-citationCommunity-Based Lifestyle Interventions to Prevent Type 2 Diabetes
Satterfield, D. W., Volansky, M., Caspersen, C. J., Engelgau, M. M., Bowman, B. A., Gregg, E. W., Geiss, L. S., Hosey, G. M., May, J. E., & Vinicor, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2643 · Cited by 157
Daniel, M., Green, L. W., Marion, S. A., Gamble, D., Herbert, C. P., Hertzman, C., & Sheps, S. B. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00403-1 · Cited by 152
Handbook of obesity—clinical applications
Levine, A. S. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.794a · Cited by 150
Genetic Prediction of Future Type 2 Diabetes
Lyssenko, V., Almgren, P., Anevski, D., Orho‐Melander, M., Sjögren, M., Saloranta, C., Tuomi, T., Groop, L., & the Botnia Study Group (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020345 · Cited by 146
Associations of body composition with Type 2 diabetes mellitus
Han, T. S., Feskens, E. J. M., Lean, M. E. J., & Seidell, J. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199802)15:2<129::aid-dia535>3.0.co;2-2 · Cited by 134
Florez, J. C., Jablonski, K. A., Sun, M. W., Bayley, N., Kahn, S. E., Shamoon, H., Hamman, R. F., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2275 · Cited by 132
Self-citationFlorez, J. C., Jablonski, K. A., Kahn, S. E., Franks, P. W., Dabelea, D., Hamman, R. F., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2007) · Diabetes · doi:10.2337/db06-0966 · Cited by 127
Self-citationMari, A., Manco, M., Guidone, C., Nanni, G., Castagneto, M., Mingrone, G., & Ferrannini, E. (2006) · Diabetologia · doi:10.1007/s00125-006-0337-x · Cited by 111
Lachin, J. M., Christophi, C. A., Edelstein, S. L., Ehrmann, D. A., Hamman, R. F., Kahn, S. E., Knowler, W. C., Nathan, D. M., & on behalf of the DPP Research Group (2007) · Diabetes · doi:10.2337/db06-0918 · Cited by 107
Self-citationDevelopment of a Primary Prevention Program: Insight Gained in the Zuni Diabetes Prevention Program
Teufel, N. I., & Ritenbaugh, C. K. (1998) · Clinical Pediatrics · doi:10.1177/000992289803700211 · Cited by 98
Laukkanen, O., Pihlajamäki, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne‐Parikka, P., Keinanen-Kiukaanniemi, S. M., Tuomilehto, J. O., Uusitupa, M. I. J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1204 · Cited by 85
Bienestar: A Diabetes Risk‐Factor Prevention Program
Treviño, R. P., Pugh, J. A., Hernández, A. E., Menchaca, V. D., Ramirez, R. R., & Mendoza, M. (1998) · Journal of School Health · doi:10.1111/j.1746-1561.1998.tb07192.x · Cited by 81
Mediators of Lifestyle Behavior Change in Native Hawaiians
Mau, M. K. L. M., Glanz, K., Severino, R., Grove, J., Johnson, B., & Curb, J. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1770 · Cited by 74
Prevention of Type 2 Diabetes in Childhood
Cook, V., & Hurley, J. (1998) · Clinical Pediatrics · doi:10.1177/000992289803700210 · Cited by 63
Efficacy of acarbose in Chinese subjects with impaired glucose tolerance
Pan, C., Gao, Y. H., Chen, J., Luo, B.-Y., Zu-zhi, F., Lu, J., Guo, X., & Cheng, H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00117-7 · Cited by 60
Glucose tolerance and mortality, including a substudy of tolbutamide treatment
Knowler, W. C., Sartor, G., Melander, A., & Scherstén, B. (1997) · Diabetologia · doi:10.1007/s001250050734 · Cited by 58
Self-citationHolcomb, J. D., Lira, J., Kingery, P. M., Smith, D. W., Lane, D. S., & Goodway, J. (1998) · Journal of School Health · doi:10.1111/j.1746-1561.1998.tb00584.x · Cited by 55
Vijgen, S. M. C., Hoogendoorn, M., Baan, C. A., de Wit, G. A., Limburg, W., & Feenstra, T. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624050-00002 · Cited by 54
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
Meece, J. D. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167336 · Cited by 54
Hämäläinen, H., Rönnemaa, T., Virtanen, A., Lindström, J., Eriksson, J. G., Valle, T. T., Ilanne‐Parikka, P., Keinanen-Kiukaanniemi, S. M., Rastas, M., Aunola, S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1938-5 · Cited by 50
Wen-ying, Y. (2001) · Zhonghua neifenmi daixie zazhi · Cited by 44
Rowley, K., Gault, A., McDermott, R., Knight, S., McLeay, T., & O’Dea, K. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.898 · Cited by 43
A project to reduce the burden of diabetes in the African-American Community: Project DIRECT.
Engelgau, M. M., Narayan, K. M. V., Geiss, L. S., Thompson, T. J., Beckles, G. L., Lopez, L., Hartwell, T., Visscher, W. A., & Liburd, L. C. (1998) · PubMed · Cited by 38
STOP Diabetes! An Educational Model for Native American Adolescents in the Prevention of Diabetes
Marlow, E., Melkus, G. D., & Bosma, A. M. (1998) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179802400403 · Cited by 30
Trying To Predict the Future for People with Diabetes: A Tough but Important Task
Engelgau, M. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00011 · Cited by 26
Bjärås, G., Härberg, L. K., Sydhoff, J., & Östenson, C. (2001) · Patient Education and Counseling · doi:10.1016/s0738-3991(99)00119-6 · Cited by 26
A pilot diabetes awareness and exercise programme in a multiethnic workforce.
Simmons, D. S., Fleming, C., Cameron, M., & Leakehe, L. (1996) · PubMed · Cited by 17
Trials that matter: Rosiglitazone, ramipril, and the prevention of type 2 diabetes
Nathan, D. M., & Berkwits, M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-6-200703200-00015 · Cited by 14
Self-citationPrediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4
Research works printed but not linked: 5
- Holman RR et al. (2007) Results from the early diabetes intervention trials [abstract]. Diabetes 52 (Suppl 1): A16
- Ackermann RT et al. (2007) Translating the Diabetes Prevention Program into the community: the YMCA model [abstract]. Diabetes 67 (Suppl 1): A42
- Ratner R (2004) Community-based identification of pre-diabetes: efficient screening techniques for implementation of diabetes prevention strategies [abstract]. Diabetes 61 (Suppl 1): A290
- Seidel MC et al. (2007) Translating the Diabetes Prevention Program (DPP) in an urban underserved community: long term sustainability of positive clinical outcomes [abstract]. Diabetes 67 (Suppl 1): A42
- Simmons D et al. (1998) A pilot urban church-based programme to reduce risk factors for diabetes among Western Samoans in New Zealand. Diabet Med 15: 136–142 · doi:10.1002/(sici)1096-9136(199802)15:2<136::aid-dia530>3.0.co;2-p
Cited by
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Lack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
What Influences Saturation? Estimating Sample Sizes in Focus Group Research
Hennink, M. M., Kaiser, B. N., & Weber, M. B. (2019) · Qualitative Health Research · doi:10.1177/1049732318821692 · Cited by 1,162
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metadata
- Authors
- F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M.
- Affiliations
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- VA Puget Sound Health Care System (US)
- Indiana University (US)
- Louisiana State University (US)
- The University of Texas at San Antonio Health Science Center (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Harvard University (US)
- Corresponding author
- Crandall, Jill P
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-05-20
- Volume
- 4
- Issue
- 7
- Pages
- 382-393
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- PMC
- PMC2573045
- OpenAlex
- W2034419419
- Cited by
- 261
- References
- 100
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 16 · 2023: 24 · 2022: 9 · 2021: 20 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 9 · 2015: 18 · 2014: 15 · 2013: 12 · 2012: 28
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK069000, U01DK048489)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, prediabetes, insulin secretion, insulin resistance, lifestyle modification, weight loss, physical activity, metformin, thiazolidinediones, acarbose, cardiovascular risk factors, cost-effectiveness, high-risk groups
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Life Style, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.